Ligand profile

ZINC6894966

Virtual-screening candidate from ZINC.

Bound to: VK055_1800 — succinate dehydrogenase, cytochrome b556 subunit

Via homolog UniProt P69054 Formula C₁₈H₁₈N₂O₃S₂
Tanimoto 0.54
Mol. weight 374.49 Da
Permeability High
PAINS Clean

Identifiers

Database identifiers and provenance.

Ligand ID
ZINC6894966
UniProt (similar protein)
P69054
Tanimoto
0.537
Target protein
VK055_1800

Structure

2D representation rendered from SMILES.

Physicochemical properties

Computed with RDKit from SMILES.

Molecular weight 374.49 Da
LogP (Crippen) 3.61
H-bond donors 2
H-bond acceptors 5
TPSA 67.43 Ų
Rotatable bonds 5
Aromatic rings 2 / 3
Heavy atoms 25
Fraction sp³ C 0.22
Formula C₁₈H₁₈N₂O₃S₂

Drug-likeness

Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.

Permeability proxy High

Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.

  • TPSA ≤ 90 Ų 67.4
  • −1 ≤ LogP ≤ 5 3.61
Lipinski's Rule of Five Pass 0 violations
  • MW ≤ 500 Da 374.5
  • LogP ≤ 5 3.61
  • H-bond donors ≤ 5 2
  • H-bond acceptors ≤ 10 5
Veber's rules Pass
  • Rotatable bonds ≤ 10 5
  • TPSA ≤ 140 Ų 67.4
PAINS Clean

No PAINS structural alerts detected.

Chemical representations

Canonical representations for cheminformatics workflows.

SMILES 
CC1=C(C(=O)Nc2ccccc2C(=O)NCc2cccs2)SCCO1
InChI 
InChI=1S/C18H18N2O3S2/c1-12-16(25-10-8-23-12)18(22)20-15-7-3-2-6-14(15)17(21)19-11-13-5-4-9-24-13/h2-7,9H,8,10-11H2,1H3,(H,19,21)(H,20,22)
InChIKey 
VUITUCWRAWFBHL-UHFFFAOYSA-N

Provenance

Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.

Method
LigQ sequence
Query
CBE
Homolog
P69054

External resources

Open this ligand in third-party databases and cheminformatics tools.

Other ligands for this protein

Quick navigation to other ligands bound to VK055_1800.

PDB 11

Ligands co-crystallized with this protein (structural evidence).

Ligand PDB entry

ZINC 49

Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).

Compound Similarity (Tanimoto)